Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBAX
DateTimeSourceHeadlineSymbolCompany
02/14/20244:48PMBusiness WirePhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
06/07/20236:05AMEdgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
06/05/20239:27AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
06/05/20238:00AMBusiness WireCERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell TherapeuticsNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/12/20234:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
03/24/20236:02AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/14/20233:46PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/14/20231:52PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/14/20236:11AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
01/25/20237:25AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/20/20224:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/07/20224:08PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/07/20224:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/21/20228:39AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/10/20224:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/04/20224:07PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
10/31/20229:29AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
10/31/20229:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/11/20224:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/13/20224:12PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
03/24/20224:13PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/11/20224:51PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/08/20224:06PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
02/03/20228:22AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
11/22/20214:15PMGlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
10/08/20214:00PMGlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment OptionNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
10/05/20215:19PMGlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public OfferingNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAX